NIPH Clinical Trials Search

UMIN ID: UMIN000001048

Registered date:01/03/2008

The multicenter phase II study of opioid based pain control program for head and neck cancer patients recieving chemoradiotherapy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHead and neck cancer
Date of first enrollment2008/03/01
Target sample size110
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Opioid based pain control program


Primary OutcomeThe frequency of treatment interruption caused by severe stmatitis or mucocitis
Secondary Outcomethe rate of completion of radiotherapy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum70years-old
GenderMale and Female
Include criteria
Exclude criteria1 women who are pregnant or breast feeding 2 with mental disorder 3 recieve the systemic therapy of steroid continuously 4 have the history of Miocardial infarction within 3 months 5 recieve the opioid therapy for cancer pain 6 with sever active co-mobidity (COPD, interstitial pneumonitis, angina pectoris and so on) 7 with severe infectious disease 8 do not agree with constructing PEG 9 with collagenosis

Related Information


public contact
Name Sadamoto Zenda
Address 6-5-1 kashiwanoha Kashiwa city chiba, Japan Japan
Telephone 04-7133-1111
Affiliation National Cancer Center Hospital East Radiation Oncology Division
scientific contact
Name Masao
Address 5-1-1 Tsukiji Chuo-ku Tokyo, Japan Japan
Telephone 0
Affiliation National Cancer Center Hospital Head and Neck Surgery